Welcome to our dedicated page for CoreWeave SEC filings (Ticker: CRWV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CoreWeave, Inc. filings document the regulatory record for an AI cloud infrastructure company listed on Nasdaq with Class A common stock. The company’s 8-K reports cover operating results, customer cloud-capacity agreements, private placements of equity securities, senior notes, credit facilities, and related guarantees or collateral arrangements.
Proxy materials disclose annual meeting matters, stockholder voting items, board governance, executive compensation, and equity-award information. Capital-structure filings describe senior unsecured notes due 2031, subsidiary guarantees, private placement registration rights, and debt facilities used to finance GPU servers and related infrastructure for customer contracts.
Nitin Agrawal, Chief Financial Officer of CoreWeave, Inc. (CRWV), reported multiple sales of Class A common stock on 09/16/2025 executed under a Rule 10b5-1 trading plan adopted May 22, 2025. Collectively, the reported transactions disposed of 38,422 shares across several tranches at weighted-average prices ranging approximately from $115.41 to $125.31, leaving the reporting person with 145,588 shares held directly. The filing also discloses 115,905 shares held directly by the reporting person’s spouse and 57,952 shares held by the Yosemite 2025 GRAT, of which the reporting person is sole trustee and beneficiary. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/18/2025.
McBee Brannin, Chief Development Officer of CoreWeave, Inc. (CRWV), reported multiple transactions on 09/16/2025. The filing shows conversions of 625,000 Class B shares into Class A shares (reported as acquisitions) and a series of sales of Class A Common Stock executed under a Rule 10b5-1 trading plan adopted May 20, 2025. Sales occurred in multiple tranches at weighted-average prices within specified ranges from about $115.35 to $125.39, reducing both direct and indirect holdings. The filing details remaining beneficial ownership counts for direct and various trust/related accounts.
Magnetar-related entities reported multiple sales of CoreWeave, Inc. (CRWV) Class A common stock on 09/17/2025. The filings show a series of dispositions at weighted-average prices of approximately $119.06, $119.97 and $121.17, with transaction price ranges disclosed as $118.75–$119.50, $119.75–$120.51 and $120.95–$121.50. The Form 4 lists multiple blocks sold across funds (Magnetar Xing He Master Fund Ltd; Purpose Alternative Credit Fund - F LLC; Purpose Alternative Credit Fund - T LLC; Longhorn Special Opportunities Fund LP) while reporting remaining indirect beneficial ownership positions (for example, 4,417,607 shares indirectly held in aggregate). The filing is signed by an attorney-in-fact on behalf of David J. Snyderman and includes customary disclaimers of beneficial ownership except for pecuniary interests.
Magnetar-related reporting persons disclosed multiple sales of CoreWeave, Inc. (CRWV) Class A common stock on 09/17/2025. The Form 4 lists numerous dispositions executed at weighted-average prices in several ranges (approximately $118.50–$121.50 per share), with individual line items showing sales from 1,218 shares up to 206,824 shares. Post-transaction beneficial ownership figures appear throughout the filing, with several indirect holdings reported in the millions of shares (examples include 28,251,939, 11,178,750 and 9,531,882 shares). Footnotes explain the reporting chain: Magnetar Financial LLC is adviser to multiple Magnetar funds, Magnetar Capital Partners LP is the sole member of Magnetar Financial, Supernova Management LLC is the general partner, and David J. Snyderman is manager; each disclaims beneficial ownership except for pecuniary interest. The transactions were signed by an attorney-in-fact on behalf of the reporting parties.
CoreWeave insider Form 4 shows multiple sales by Magnetar-related reporting persons on 09/16/2025. The filing reports numerous dispositions of Class A common stock executed on that date at weighted-average prices reported in three groups (footnotes show price ranges of $121.00–$121.99, $122.07–$122.73 and $123.27–$123.75) and an additional listed price of $124.65. Sales were executed by or on behalf of Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC and David J. Snyderman, with securities held across several Magnetar funds. The filing discloses indirect beneficial ownership positions by various Magnetar funds and related entities, with an aggregated reported indirect holding line of 4,417,607 Class A shares reported in the table.
Magnetar-affiliated reporting persons filed a Form 4 disclosing multiple dispositions of Class A Common Stock of CoreWeave, Inc. (CRWV) executed on 09/16/2025. Several Magnetar entities and related parties sold shares in multiple transactions at weighted-average prices reported between $118.93 and $124.65 (with trade ranges noted in footnotes). The filings show remaining indirect beneficial ownership positions for various Magnetar funds and entities, with per-entity post-transaction holdings listed in the table. The submission includes standard disclaimers that the reporting persons disclaim beneficial ownership except for pecuniary interest and identifies the reporting chain from Magnetar Financial LLC up to David J. Snyderman.
Insiders affiliated with Magnetar disclosed multiple sales of CoreWeave Class A common stock on 09/15/2025. The Form 4 shows numerous dispositions by Magnetar Financial LLC and related entities, executed at weighted-average prices reported in three ranges: $119.61–$120.52, $120.65–$120.90, and $119.86–$120.68. The filing lists many individual sell transactions across several Magnetar-managed funds and indicates sizable continuing indirect beneficial ownership of CoreWeave shares held by those funds. The report includes footnotes identifying which fund directly holds each block of shares and states that the reporting parties disclaim beneficial ownership except for pecuniary interest.
CoreWeave and Core Scientific have entered into a merger agreement under which Merger Sub will merge into Core Scientific and each outstanding share of Core Scientific common stock (other than excluded shares) will be converted into the right to receive 0.1235 shares of CoreWeave Class A common stock. Based on CoreWeave's $165.20 closing price on July 3, 2025, the exchange ratio implied approximately $20.40 per Core Scientific share. The Core Scientific board unanimously approved and recommends the Merger Agreement and a non-binding advisory vote on related executive compensation. Completion requires a majority of outstanding Core Scientific shares, regulatory clearances (including HSR), effectiveness of an S-4 registration statement and Nasdaq listing approval for the issued CoreWeave shares. Core Scientific stockholders will have no appraisal rights. Certain equity awards will vest, convert or be canceled per the agreement; some outstanding options that are out-of-the-money will be cancelled with no consideration. A $270 million termination fee and restrictions on solicitation are included in the Merger Agreement.
CoreWeave, Inc. (CRWV) Form 144 notice reports a proposed sale of 281,250 common shares, with an aggregate market value of $33,398,437.50, to be sold on 09/17/2025 through Morgan Stanley Smith Barney LLC on NASDAQ. The securities were acquired as Founders Shares on 12/27/2023. The filing also lists multiple recent 10b5-1 programmed sales by related accounts between 08/20/2025 and 09/03/2025, including two prior 281,250-share sales and several smaller trust sales. The filer represents no undisclosed material adverse information and notes use of trading plans where applicable.
Margaret C. Whitman, a director of CoreWeave, Inc. (CRWV), reported equity awards that vested on 09/14/2025. The filing shows the reporting person acquired 100 and 1,200 shares of Class A common stock through the vesting/settlement of restricted stock units at a $0 price. Following the transactions the reported beneficial ownership figures shown are 1,380 and 2,580 shares for the two non-derivative lines and 220 and 11,960 underlying shares for the derivative lines. The RSU awards vest in scheduled tranches (quarterly on the 14th of June, September, December, March) contingent on continued service. The Form 4 was signed by an attorney-in-fact on 09/16/2025.